Cellcept and Extremity contracture - a phase IV clinical study of FDA data

Summary:

Extremity contracture is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are male, 30-39 old, have been taking the drug for 10+ years also take Magnevist, and have Pain.

The phase IV clinical study analyzes which people have Extremity contracture when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Extremity contracture?

Extremity contracture (permanent shortening of a muscle or joint of arms and legs) is found to be associated with 208 drugs and 258 conditions by eHealthMe. Check the latest studies of Extremity contracture.

On Jul, 14, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 51 people (0.12%) have Extremity contracture.

Could Cellcept cause Extremity contracture?

Among these 51 people:

How long have people been on Cellcept when they have Extremity contracture? *

What is the gender of people who have Extremity contracture when taking Cellcept? *

female: 49.02 %
male: 50.98 %

What is the age of people who have Extremity contracture when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Extremity contracture? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 48 people, 94.12%
Pain: 44 people, 86.27%
Skin Induration (an abnormally hard spot or area on the skin): 38 people, 74.51%
Skin Hypertrophy (skin cells enlarges): 37 people, 72.55%
Oedema Peripheral (superficial swelling): 35 people, 68.63%
Joint Range Of Motion Decreased (disease of joint movement): 34 people, 66.67%
Skin Tightness: 32 people, 62.75%
Rashes (redness): 31 people, 60.78%
Weakness: 30 people, 58.82%
Mobility Decreased (ability to move is reduced): 28 people, 54.90%

What are the existing conditions these people have? *

Pain: 16 people, 31.37%
Nuclear Magnetic Resonance Imaging Abdominal: 12 people, 23.53%
Nuclear Magnetic Resonance Imaging Brain: 7 people, 13.73%
Anaemia (lack of blood): 6 people, 11.76%
Diabetes: 6 people, 11.76%
High Blood Pressure: 6 people, 11.76%
Immunodeficiency Disorders: 5 people, 9.80%
Stable Angina (a constant chest pain): 3 people, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 5.88%
Blood Triglycerides Decreased: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Extremity contracture?

- Check whether Extremity contracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Extremity contracture:

Extremity contracture (208 drugs)

Browse all the conditions that are associated with Extremity contracture:

Extremity contracture (258 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.